Summarize this content to 2000 words in 6 paragraphs
Kirkland, Wash.-based Kestra Medical Technologies is aiming to raise about $150 million in its initial public offering, pricing shares between $14 and $16 on the Nasdaq, according to a new regulatory filing.
The maker of cardiac monitoring and therapeutic devices launched in 2014 and filed for an IPO earlier this month. It raised a $196 million round in 2024.
The company, backed by Bain Capital, generated revenue of $27.5 million in the six-month period ended Oct. 31, up from $9.5 million in the year-ago period. It expanded headcount from 66 people in October 2020 to more than 300 employees today.
Three of the four largest IPOs this year in the U.S. traded below their offer price in their first session, Bloomberg noted.
